494. Pharma's AI Moment: More Innovation in 12 Months Than the Previous 10 Years

494. Pharma's AI Moment: More Innovation in 12 Months Than the Previous 10 Years

From Transform NOW by SSNC Blue Prism

June 23, 2026 · 26 min

About this episode

Mahi Rayasam discusses Eli Lilly's strategic deployment of AI to enhance drug discovery and patient access.

In this episode, Brad Hairston talks with Mahi Rayasam, SVP and Information Officer at Eli Lilly and Company, who discusses how his organization is strategically deploying AI across drug discovery, clinical development, and commercialization to accelerate the delivery of life-saving medicines to patients. . What we talked about with Mahi: * Lilly’s 150th anniversary * The transition from McKinsey to technology leadership at Lilly * AI prioritization framework * LillyDirect – the direct-to-patient access model * The scientist-in-the-loop philosophy * Interdisciplinary hiring in pharma * AI adoption among scientists * Surfacing previously unreachable healthcare innovation . Visit us on our socials: 🦾 Get started with SS&C Blue Prism: https://okt.to/JcMLdU 🧑‍💻LinkedIn: https://okt.to/k8zIdp ✖️Twitter: https://okt.to/fHyd9G 🙋‍♀️Facebook: https://okt.to/Vyjfiz 📸Instagram: https://okt.to/5nYvIf 💭Blog: https://okt.to/QuGqVP 🤩Case studies: https://okt.to/ft1AMX . To ensure that you never miss an episode of Transform NOW, be sure to subscribe!

People in this episode

Host: Brad Hairston

Guest: Mahi Rayasam

Topics covered

Keywords

Mentioned in this episode

Organizations: Eli Lilly and Company, McKinsey

Products: LillyDirect

More episodes of Transform NOW

Explore listener stats, chart rankings, contacts and more on the Transform NOW podcast page.